Pharmacogenomics

Pharmacogenomics

The study of the role of the genome in medication response is known as pharmacogenomics. The combination of pharmacology and genetics is reflected in the term (pharmaco- + genomics). Pharmacogenomics studies how a person's genetic composition influences their pharmacological reaction. It examines the impact of acquired and inherited genetic variation on drug response in patients by linking gene expression or single-nucleotide polymorphisms to pharmacokinetics (drug absorption, distribution, metabolism, and elimination) and pharmacodynamics (effects mediated by a drug's biological targets). The terms pharmacogenomics and pharmacogenetics are frequently used interchangeably. Although both names refer to medication response influenced by genetic factors, pharmacogenetics focuses on single drug-gene interactions, whereas pharmacogenomics takes a more genome-wide approach, including genomics and epigenetics while addressing the impact of numerous genes on drug response.

 

  • Stroke Diagnosis
  • Text mining

Related Conference of Pharmacogenomics

March 18-19, 2024

53rd World Congress on Microbiology

Zurich, Switzerland
May 09-10, 2024

16th International Virology Summit

Barcelona, Spain
June 10-11, 2024

5th International Conference on Molecular Microbiology

Barcelona, Spain

Pharmacogenomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in